British Columbia
Treatments

Evrysdi – Risdiplam

Link to more information

Available:

Effective February 16, 2022 – Available through Exceptional Expensive Drugs for Rare Disease Process – no criteria available

Spinraza – Nusinersen

Link to more information

Available:

British Columbia has covered only pediatric patients, consistent with CADTH recommendation.

Zolgensma – Onasemnogene abeparvovec

https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/pharmacare-for-bc-residents/what-we-cover/exceptional-funding-edrd

Available:

EDRDs considered for exceptional case-by-case funding